These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6273648)

  • 1. Intranasal vaccine trial for canine infectious tracheobronchitis (kennel cough).
    Glickman LT; Appel MJ
    Lab Anim Sci; 1981 Aug; 31(4):397-9. PubMed ID: 6273648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine.
    Shade FJ; Goodnow RA
    Am J Vet Res; 1979 Sep; 40(9):1241-3. PubMed ID: 525927
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal vaccination of dogs with liver avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis.
    Bey RF; Shade FJ; Goodnow RA; Johnson RC
    Am J Vet Res; 1981 Jul; 42(7):1130-2. PubMed ID: 7271029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of a tracheobronchitis epizootic associated with Bordetella bronchiseptica in a closed dog colony.
    Shelton ME; Draper DD; Farrington DO
    Vet Med Small Anim Clin; 1977 Feb; 72(2):189-93. PubMed ID: 584586
    [No Abstract]   [Full Text] [Related]  

  • 6. A placebo-controlled trial of two intranasal vaccines to prevent tracheobronchitis (kennel cough) in dogs entering a humane shelter.
    Edinboro CH; Ward MP; Glickman LT
    Prev Vet Med; 2004 Feb; 62(2):89-99. PubMed ID: 15156996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
    Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
    Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of canine parainfluenza virus and Bordetella bronchiseptica in kennel cough.
    Wagener JS; Sobonya R; Minnich L; Taussig LM
    Am J Vet Res; 1984 Sep; 45(9):1862-6. PubMed ID: 6093651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field evaluation of an intranasally administered canine parainfluenza-Bordetella bronchiseptica vaccine.
    Alkire LT; Chladek DW
    Vet Med Small Anim Clin; 1980 Jun; 75(6):1003-5. PubMed ID: 6254224
    [No Abstract]   [Full Text] [Related]  

  • 10. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs.
    Keil DJ; Fenwick B
    J Am Vet Med Assoc; 1998 Jan; 212(2):200-7. PubMed ID: 9448823
    [No Abstract]   [Full Text] [Related]  

  • 12. Canine infectious tracheobronchitis.
    Compend Contin Educ Vet; 2007 Jul; 29(7):418-9. PubMed ID: 17727049
    [No Abstract]   [Full Text] [Related]  

  • 13. Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours.
    Gore T; Headley M; Laris R; Bergman JG; Sutton D; Horspool LJ; Jacobs AA
    Vet Rec; 2005 Apr; 156(15):482-3. PubMed ID: 15828745
    [No Abstract]   [Full Text] [Related]  

  • 14. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity.
    Chladek DW; Williams JM; Gerber DL; Harris LL; Murdock FM
    Am J Vet Res; 1981 Feb; 42(2):266-70. PubMed ID: 6266289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica.
    Davis R; Jayappa H; Abdelmagid OY; Armstrong R; Sweeney D; Lehr C
    Vet Ther; 2007; 8(1):32-40. PubMed ID: 17447223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental production of canine tracheobronchitis (kennel cough) with canine herpesvirus isolated from naturally infected dogs.
    Karpas A; Garcia FG; Calvo F; Cross RE
    Am J Vet Res; 1968 Jun; 29(6):1251-7. PubMed ID: 4297857
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica.
    Iemura R; Tsukatani R; Micallef MJ; Taneno A
    Vet Rec; 2009 Dec; 165(25):747-51. PubMed ID: 20023279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular necrosis associated with the subcutaneous injection of an intranasal Bordetella bronchiseptica-canine parainfluenza vaccine.
    Toshach K; Jackson MW; Dubielzig RR
    J Am Anim Hosp Assoc; 1997; 33(2):126-8. PubMed ID: 9111722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus 2, Bordetella bronchiseptica, and Parainfluenza Molecular Diagnostic Assay Results in Puppies After vaccination with Modified Live Vaccines.
    Ruch-Gallie R; Moroff S; Lappin MR
    J Vet Intern Med; 2016; 30(1):164-6. PubMed ID: 26692461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
    Larson LJ; Schultz RD
    Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.